An sGC stimulator that increases the activity of sGC in vitro by up to 73-fold and acts in synergy with nitric oxide to increase sGC activity up to 122-fold; promotes vasodilation in several pre-clinical animal models of hypertension and has been evaluated in phase II and III clinical studies of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.